Article Versions Notes

Sato Y, Kobayashi T, Nishiumi S, Okada A, Fujita T, Sanuki T, Kobayashi M, Asahara M, Adachi M, Sakai A, et al. Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer. Cancers. 2020; 12(9):2625. https://doi.org/10.3390/cancers12092625

Sato, Yu, Takashi Kobayashi, Shin Nishiumi, Akihiko Okada, Tsuyoshi Fujita, Tsuyoshi Sanuki, Masao Kobayashi, Masakyo Asahara, Masayasu Adachi, Arata Sakai, and et al. 2020. "Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer" Cancers 12, no. 9: 2625. https://doi.org/10.3390/cancers12092625

Sato, Y., Kobayashi, T., Nishiumi, S., Okada, A., Fujita, T., Sanuki, T., Kobayashi, M., Asahara, M., Adachi, M., Sakai, A., Shiomi, H., Masuda, A., Yoshida, M., Takeuchi, K., Kodama, Y., Kutsumi, H., Nagashima, K., & Honda, K. (2020). Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer. Cancers, 12(9), 2625. https://doi.org/10.3390/cancers12092625